IEX reported a 14.7% YoY increase in its PAT on May 15 along with a revenue at Rs 149.5 crore for the fourth quarter of the financial year 2024.
Vijay Kedia buys 9 lakh shares of SME stock Mahamaya Lifesciences in Rs 12.5 crore block deal
Ace investor Vijay Kedia acquired a significant stake in Mahamaya Lifesciences through a block deal. He purchased nearly 9 lakh shares at Rs 140 each.